A week ago, Penumbra, Inc. (NYSE:PEN) came out with a strong set of third-quarter numbers that could potentially lead to a re-rate of the stock. It was overall a positive result, with revenues beating ...

Shares of medical device company Penumbra (NYSE:PEN) fell 5.5% in the afternoon session after the company announced results from its landmark STORM-PE randomized controlled trial. The study found that ...

Penumbra took the TCT (Transcatheter Cardiovascular Therapeutics) by storm on Sunday with the results of its landmark STORM-PE randomized controlled trial. The Alameda, CA-based company reported that ...

The setting of a “post-apocalyptic dystopia” has become such a staple of modern literature – and the resultant cinematic adaptations – that your public library could reserve a room for books that fit ...

Reader question: What's going on with the TDS fiber rollout? Haven't heard anything in the last couple years, but still getting emails. Is construction still happening? Answer: In 2022, the Green Bay ...

ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Penumbra Inc. (PEN) on Tuesday reported second-quarter earnings of $45.3 million. The Alameda, California-based company said it had net income of $1.15 ...

Sales of $324.1 million, up 16.3% year over year (+16.9% in constant currency) and beating the consensus of $315.66 million. Adjusted EPS of 83 cents, beating the consensus of 67 cents. Revenue from ...

There are many different types of laughter. There is the good laughter caused by joy, surprise, happiness, or perhaps even ecstasy. There is laughter at the absurd when one cannot even make sense of ...

Traffic distribution systems (TDSs) have long been a security risk, but abuse of underground and commercial TDS platforms may be on the rise — and perhaps harder to stop. TDSs are traffic management ...

Bank of America launched its coverage of medical device maker Penumbra (NYSE:PEN) with a Buy recommendation on Friday, citing a broader commercial rollout of the company’s latest clot-removal product, ...